Acute exacerbation of chronic obstructive pulmonary disease

When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Last reviewed: 22 Nov 2024
Last updated: 10 Dec 2024

Summary

Definition

History and exam

Key diagnostic factors

  • dyspnea
  • cough
  • wheeze
  • changes in sputum volume/color/thickness
  • tachypnea
  • cyanosis
Full details

Other diagnostic factors

  • past medical history of COPD
  • tobacco dependence
  • past medical history of gastroesophageal reflux/swallowing dysfunction
  • malaise and fatigue
  • chest tightness
  • features of cor pulmonale
  • environmental/occupational exposure to pollutants or dust
  • change in mental status
  • fever
  • accessory muscle use
  • paradoxical movements of abdomen
Full details

Risk factors

  • viral infection
  • bacterial infection
  • gastroesophageal reflux/swallowing dysfunction
  • smoking
  • atypical bacterial infection
  • air pollutants
  • change in weather
Full details

Diagnostic tests

1st tests to order

  • oxygen saturation on pulse oximetry
  • chest x-ray
  • ECG
  • ABG
  • CBC with differential
  • eosinophil count
  • C-reactive protein
  • basic metabolic panel for electrolytes, BUN, + creatinine
Full details

Tests to consider

  • sputum culture + Gram stain
  • respiratory virus diagnostics
  • cardiac troponin
  • B-type natriuretic peptide (BNP)
  • CT scan of chest
Full details

Emerging tests

  • procalcitonin
  • vitamin D
  • immunoglobulins
Full details

Treatment algorithm

ACUTE

at presentation

ONGOING

after stabilization

Contributors

Expert advisers

Carolyn L. Rochester, MD

Professor of Medicine

Yale School of Medicine

New Haven

VA Connecticut Healthcare System

West Haven

CT

Disclosures

CLR serves on the COPD scientific advisory board for GlaxoSmithKline Pharmaceuticals but has no competing interests pertaining to this publication.

Richard A. Martinello, MD

Associate Professor

Yale School of Medicine

New Haven

CT

Disclosures

RAM declares that he has no competing interests.

Peer reviewers

Antonio Anzueto, MD

Professor of Medicine

University of Texas Health

Section Chief

South Texas Veterans Health Care System

San Antonio

TX

Disclosures

AA has been a consultant for GlaxoSmithKline, AstraZeneca, Boehringer-Ingelheim, Theravance and Grifols. AA has been reimbursed for his services by these companies. AA is a member of the GOLD scientific committee.

  • Differentials

    • Congestive heart failure
    • Pneumonia
    • Pleural effusion
    More Differentials
  • Guidelines

    • Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease
    • Chronic obstructive pulmonary disease: screening
    More Guidelines
  • Videos

    Dry powder inhalers

    Soft mist inhaler

    More videos
  • Patient information

    COPD

    COPD: what is it?

    More Patient information
  • padlock-lockedLog in or subscribe to access all of BMJ Best Practice

Use of this content is subject to our disclaimer